A coronavirus treatment touted by Prime Minister Benjamin Netanyahu as a “miracle drug” earlier this year has been approved by the Health Ministry for a Phase II/III trial, according to the hospital in which it was developed.
Prof. Nadir Arber of Tel Aviv Sourasky Medical Center told The Jerusalem Post that his EXO-CD24 COVID-19 treatment will soon launch a double-blind placebo trial in which around 150 patients in moderate or serious condition will be treated with the medication.
Because the level of COVID-19 in Israel is extremely low, Sourasky will partner with other medical centers throughout the country, and will likely extend the trial to other countries, Arber said.
The treatment is being tested in Greece in what is known as a dosing study to determine how much of the treatment is needed to most effectively treat COVID-19.
From an article in the Jerusalem Post
Read the rest of the article here
Introducing our new collection of Botanical Jewelry
Make your Summer Sale shopping in our store today
